Toxoplasmosis: New challenges for an old disease

Eye

Volumn 26, Issue 2, 2012, Pages 241-244

  Bodaghi, B ^a   Touitou, V ^a   Fardeau, C ^a   Paris, L ^a   Lehoang, P ^a  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

Author keywords

Goldmann Witmer coefficient; prophylaxis; recurrence; retinochoroiditis; toxoplasmosis

Indexed keywords

ATOVAQUONE; AZITHROMYCIN; CLARITHROMYCIN; CLINDAMYCIN; CORTICOSTEROID; COTRIMOXAZOLE; DEXAMETHASONE; FOLINIC ACID; METHYLPREDNISOLONE; MINOCYCLINE; PREDNISOLONE; PREDNISONE; PYRIMETHAMINE; SPIRAMYCIN; SULFADIAZINE; SULFAMETHOXAZOLE; TRIMETHOPRIM;

CHORIORETINITIS; CLINICAL FEATURE; CONFERENCE PAPER; DIAGNOSTIC PROCEDURE; DIAGNOSTIC VALUE; DISEASE SEVERITY; DRUG EFFICACY; DRUG SAFETY; EYE INFLAMMATION; HUMAN; IMMUNE RESPONSE; NONHUMAN; RISK FACTOR; TOXOPLASMA GONDII; TOXOPLASMOSIS; TREATMENT DURATION; TREATMENT PLANNING; UVEITIS; VISION;

EID: 84856616694     PISSN: 0950222X     EISSN: 14765454     Source Type: Journal    
DOI: 10.1038/eye.2011.331     Document Type: Conference Paper

References (21)

1. Wakefield D, Cunningham Jr ET, Pavesio C, Garweg JG, Zierhut M. Controversies in ocular toxoplasmosis. Ocul Immunol Inflamm 2011; 19(1): 2-9.
2. Nicolle C, Manceaux L. Sur une infection à corps de Leishman (ou organismes voisins) du gondi. CR Seances Acad Sci 1908; 147: 763-766.
3. Nicolle C, Manceaux L. Sur un protozoaire nouveau du gondi. CR Seances Acad Sci 1909; 148: 369-372.
4. Splendore A. Un nuovo protozoa parassita de' conigli. incontrato nelle lesioni anatomiche d'une malattia che ricorda in molti punti il Kala-azar dell' uomo. Nota preliminare pel Rev Soc Scient Sao Paulo 1908; 3: 109-112.
5. Chatton E, Blanc G. Notes et reflexions sur le toxoplasme et la toxoplasmose du gondi. (Toxoplsma gundii Ch. Nicolle et Manceaux 1909). Arch Inst Pasteur Tunis 1917; 10: 1-41.
6. Jankû J. Pathogensa a pathologica anatomie T. Zv. vrozaneho kolobou zlute skurney oku normal ne velikem a mikrophtalmickem s nalezem parisitu v sitnici. Cas Lek Ses 1923; 62: 1021-1027.
7. Wolf A, Cowen D, Paige B. Human toxoplasmosis: occurence in infants as an encephalomyelitis; verification by transmission to animals. Science 1939; 86: 226-227.
8. Dubey JP. History of the discovery of the life cycle of Toxoplasma gondii. Int J Parasitol 2009; 39(8): 877-882.
9. Commodaro AG, Belfort RN, Rizzo LV, Muccioli C, Silveira C, Burnier Jr MN et al. Ocular toxoplasmosis: an update and review of the literature. Mem Inst Oswaldo Cruz 2009; 104(2): 345-350.
10. Talabani H, Mergey T, Yera H, Delair E, Brezin AP, Langsley G et al. Factors of occurrence of ocular toxoplasmosis. A review. Parasite 2010; 17(3): 177-182.
11. Vallochi AL, Goldberg AC, Falcai A, Ramasawmy R, Kalil J, Silveira C et al. Molecular markers of susceptibility to ocular toxoplasmosis, host and guest behaving badly. Clin Ophthalmol 2008; 2(4): 837-848.
12. Vaudaux JD, Muccioli C, James ER, Silveira C, Magargal SL, Jung C et al. Identification of an atypical strain of toxoplasma gondii as the cause of a waterborne outbreak of toxoplasmosis in Santa Isabel do Ivai, Brazil. J Infect Dis 2010; 202(8): 1226-1233.
13. Jones JL, Holland GN. Annual burden of ocular toxoplasmosis in the US. Am J Trop Med Hyg 2010; 82(3): 464-465.
14. Garweg JG, Scherrer JN, Halberstadt M. Recurrence characteristics in European patients with ocular toxoplasmosis. Br J Ophthalmol 2008; 92(9): 1253-1256.
15. Holland GN. Ocular toxoplasmosis: the influence of patient age. Mem Inst Oswaldo Cruz 2009; 104(2): 351-357.
16. Holland GN, Crespi CM, ten Dam-van Loon N, Charonis AC, Yu F, Bosch-Driessen LH et al. Analysis of recurrence patterns associated with toxoplasmic retinochoroiditis. Am J Ophthalmol 2008; 145(6): 1007-1013.
17. Fekkar A, Ajzenberg D, Bodaghi B, Touafek F, Le Hoang P, Delmas J et al. Direct genotyping of Toxoplasma gondii in ocular fluid samples from 20 patients with ocular toxoplasmosis: predominance of type II in France. J Clin Microbiol 2011; 49(4): 1513-1517.
18. Gilbert RE, See SE, Jones LV, Stanford MS. Antibiotics versus control for toxoplasma retinochoroiditis. Cochrane Database Syst Rev 2002; (1): CD002218.
19. Stanford MR, Gilbert RE. Treating ocular toxoplasmosis: current evidence. Mem Inst Oswaldo Cruz 2009; 104(2): 312-315.
20. Soheilian M, Ramezani A, Azimzadeh A, Sadoughi MM, Dehghan MH, Shahghadami R et al. Randomized trial of intravitreal clindamycin and dexamethasone versus pyrimethamine, sulfadiazine, and prednisolone in treatment of ocular toxoplasmosis. Ophthalmology 2011; 118(1): 134-141.
21. Silveira C, Belfort Jr R, Muccioli C, Holland GN, Victora CG, Horta BL et al. The effect of long-term intermittent trimethoprim/sulfamethoxazole treatment on recurrences of toxoplasmic retinochoroiditis. Am J Ophthalmol 2002; 134(1): 41-46. (Pubitemid 34722708)